vol. 61 July 2025

KOBE Biomedical Innovation Cluster newsletter vol. 61
- July 2025 -

vol. 61 July 2025

Hello,

In September, we are planning to exhibit as “Kobe Pavilion” at Medical Fair Thailand bringing 5 KBIC companies to be held on Sep 10-12 2025 in Bangkok. This time, we are planning a delegation tour prior to the trade fair to visit the science park, governmental organization, university hospital, private hospital and so on. To prepare the tour, visited Thailand this month. It was truly inspiring to meet with enthusiatic people working hard to make the medical treatment better in the country. Also the city was quite vibrant. We are looking forward to showcasing innovative products and technology of KBIC companies in Bangkok in September!

If you missed our past issues of KBIC newsletter, please visit Newsletter Archive.

FBRI Editorial Team

NEWS

Cyto-Facto Launches “CytoFactory 4.0™ ” A Cloud-Based Integrated Manufacturing Management System for ATMP Production

Optimizing quality, speed, and compliance in gene and cell therapy manufacturing

Kobe, Japan Cyto-Facto Inc. (Head Office: Kobe, Hyogo; CEO: Shin Kawamata) today announced the official launch of CytoFactory 4.0™ Ver.1, a cloud-based integrated manufacturing management system designed specifically for the production of advanced therapy medicinal products (ATMPs).
As gene and cell therapies move toward widespread clinical use, many manufacturing facilities continue to face challenges in digitization and operational efficiency. Paper-based batch records and manual workflows are still common, often resulting in hundreds of pages per batch, significant labor, and increased risk of human error. Additionally, the highly personalized and complex nature of cell therapy production makes conventional manufacturing systems ill-suited for the task.
CytoFactory 4.0™ was developed to address these challenges head-on, under the concept of “transforming the future of cell therapy manufacturing through purpose-built digital solutions.”

Demonstration of Remote Surgery Using the hinotori™ Surgical Robot System Successfully Performed by Medicaroid Corporation Between Europe and Japan

Japan Surgical Society, Medicaroid Corporation (HQ: Kobe, Japan; Board Director, CEO and President Koji Muneto), NTT Communications Corporation (Head Office: Chiyoda-ku, Tokyo, President and CEO: Katsushige Kojima) succeeded in a demonstration of remote surgery between Strasbourg, France and Kobe, Japan by the hinotori™ Surgical Robot System.